Douglas Fitzwater
Pediatrics · Portageville, MONPI 1619967106
Payments from drug & device makers
Across 111 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$319
- Phathom Pharmaceuticals, Inc.$318
- Amarin Pharma, Inc.$227
- Merck$209
- GSK$154
- Novo Nordisk$148
- plus $617 from 14 others
What the payments were for
- Food & beverage$1,97799%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $319 |
| Phathom Pharmaceuticals, Inc. | 6 | $318 |
| Amarin Pharma, Inc. | 22 | $227 |
| Merck | 14 | $209 |
| GSK | 12 | $154 |
| Novo Nordisk | 8 | $148 |
| Lilly USA, LLC | 7 | $98 |
| Boehringer Ingelheim | 6 | $93 |
| Teva Pharmaceuticals USA, Inc. | 1 | $89 |
| Johnson & Johnson | 4 | $74 |
| Novartis | 3 | $49 |
| Eisai Inc. | 3 | $41 |
| Grifols USA, LLC | 1 | $38 |
| Sunovion Pharmaceuticals Inc. | 2 | $30 |
| Axonics, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Pfizer | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Bayer | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,992 in reported general payments places this provider in the 90th percentile of 1,306 pediatrics providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 55 | $59,034 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 72 | $48,242 |
| FarxigaDapagliflozin Propanediol | 81 | $47,871 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 60 | $43,638 |
| OzempicSemaglutide | 42 | $40,681 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 60 | $28,139 |
| RexultiBrexpiprazole | 15 | $23,542 |
| EliquisApixaban | 30 | $19,764 |
| JanuviaSitagliptin Phosphate | 45 | $19,090 |
| VraylarCariprazine Hcl | 13 | $18,773 |
| BelsomraSuvorexant | 32 | $15,666 |
| TrulicityDulaglutide | 15 | $14,843 |
| VascepaIcosapent Ethyl | 39 | $14,342 |
| LinzessLinaclotide | 25 | $13,591 |
| JardianceEmpagliflozin | 16 | $10,959 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $319 | $94,054152 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Arexvy, Shingrix | $154 | $82,141156 claims |
| Lilly USA, LLCMounjaro, Trulicity | $98 | $73,87770 claims |
| Novo NordiskOzempic | $148 | $40,68142 claims |
| MerckJanuvia, Belsomra | $209 | $34,75677 claims |
| PfizerEliquis, Premarin | $18 | $22,26542 claims |
| Boehringer IngelheimJardiance, Synjardy | $93 | $18,40229 claims |
| Johnson & JohnsonXarelto, Invokamet | $74 | $13,88924 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,306 pediatrics providers in Missouri.
Other pediatrics in Portageville
- Kathleen DoisyColumbia$70.4M
- Nadine MokhallatiKansas City$10.2M
- Jennifer DiltsKansas City$517K
- Abbey MasonbrinkKansas City$505K
- Craig SpiegelBridgeton$494K
- Amanda NedvedKansas City$201K
- Jennifer HeithausSaint Louis$182K
- Alexander FaySaint Louis$118K
- Jennifer GoldmanKansas City$114K
- David GoldsteinColumbia$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.